Towards tuberculosis elimination: an action framework for low-incidence countries

K Lönnroth, GB Migliori, I Abubakar… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(< 100 TB cases per million population) that are striving for TB elimination. The framework …

Advances in the development of new tuberculosis drugs and treatment regimens

A Zumla, P Nahid, ST Cole - Nature reviews Drug discovery, 2013 - nature.com
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …

Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data

L Wang, H Zhang, Y Ruan, DP Chin, Y Xia, S Cheng… - The Lancet, 2014 - thelancet.com
Background China scaled up a tuberculosis control programme (based on the directly
observed treatment, short-course [DOTS] strategy) to cover half the population during the …

Bedaquiline in the treatment of multidrug-and extensively drug-resistant tuberculosis

AS Pym, AH Diacon, SJ Tang… - European …, 2016 - Eur Respiratory Soc
Bedaquiline, a diarylquinoline, improved cure rates when added to a multidrug-resistant
tuberculosis (MDR-TB) treatment regimen in a previous placebo-controlled, phase 2 trial …

The path to tuberculosis elimination: a renewed vision

GB Migliori, D Dowdy, JT Denholm… - European …, 2023 - Eur Respiratory Soc
Tuberculosis (TB) elimination and pre-elimination, with thresholds of 1 and 10 incident
cases per million population, respectively, were considered achievable for low TB incidence …

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

AI Zumla, SH Gillespie, M Hoelscher… - The Lancet infectious …, 2014 - thelancet.com
About 1· 3 million people died of tuberculosis in 2012, despite availability of effective drug
treatment. Barriers to improvements in outcomes include long treatment duration (resulting …

[PDF][PDF] Towards tuberculosis elimination: an action framework for low-incidence countries

TT ELIMINATION - Eur Respir J, 2015 - Citeseer
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(< 100 TB cases per million population) that are striving for TB elimination. The framework …

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

E Pontali, G Sotgiu, L D'Ambrosio… - European …, 2016 - Eur Respiratory Soc
The importance of adequately managing multidrug-resistant (MDR) and extensively drug-
resistant (XDR) tuberculosis (TB) cases for TB control and elimination are underlined in the …

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening

L Barcellini, E Borroni, J Brown… - European respiratory …, 2016 - Eur Respiratory Soc
Identifying latently infected individuals is crucial for the elimination of tuberculosis (TB). We
evaluated for the first time the performance of a new type of interferon-γ release assay …

Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation

R Diel, J Vandeputte, G de Vries, J Stillo… - European …, 2014 - Eur Respiratory Soc
Without better vaccines it is unlikely that tuberculosis (TB) will ever be eliminated. An
investment of∼€ 560 million is considered necessary to develop a new, effective vaccine in …